Clinical Lab Advisor Logo

Loading...

Daniel Sappington MS, PhD, NRCC-TC

Daniel Sappington MS, PhD, NRCC-TC


  • LCMS
  • Sciex
  • Agilent
  • Waters
  • Siemens CLINITEK
  • Siemens V-Twin

Scientific Specialty:
Chemistry, Pharmacogenetics, Toxicology, Laboratory Information Systems

Domain Specialty:
Process Improvement, Reporting Software, Teaching, Training, Laboratory Automation, Validation, Compliance, CAP, CLIA

Technical Expertise:
ELISA, Mass Spectrometry, PCR/qPCR, Quality Assurance, Quality Control, Procedure development, Immunoassay

Platform Expertise:
Hamilton, Siemens, Sciex, Waters, Agilent, Eppendorf

Location:
United States of America

Description:

Daniel Sappington is a laboratory director, manager and consultant; toxicology director of operations; and science educator with over 8 years of experience in the health sector. Daniel’s impressive educational background has earned him jobs in numerous medical facilities. In 2008, he graduated from the College of the Ozarks (Point Lookout, Missouri) with two Bachelor of Science honours in Secondary Education and Biology. In 2010, he bagged a 4.0 Masters of Science in Environmental Sciences: Biology, at the Arkansas State University. Five years after, Daniel achieved a Doctor of Philosophy (Ph.D.) in Cancer Biology at the University of Arkansas for Medical Sciences with a 3.8 CGPA.


An educator in all his alma maters, Daniel has had his fair share of lecturing. In the years building up to his career, Daniel worked as a graduate teaching assistant in Arkansas State University and as a science educator for the Arkansas School for the Deaf. Currently the laboratory director of operations at MedTech Laboratory, Daniel is the co-owner and consultant of Beyond DNA Consulting, located in Texas. He is also affiliated with numerous professional societies such as the American Society of Addiction Medicine, American Chemical Society, and the National Center for Science Education.


Daniel’s unique achievements have not gone unnoticed. He has received numerous awards and accolades for his hard work, such as being selected as chair of the steering committee of the Graduate Student Teachers of Central Arkansas; and earning a travel award from the Interdisciplinary Biomedical Sciences at UAMS. Being a board certified Toxicological Chemist, Daniel has undertaken numerous platform and poster presentations at notable meetings such as the Annual meetings of the American Chemical Society, American Association for Cancer Research, and Society of Forensic Toxicology.


CHALLENGES I CAN HELP YOU WITH

  • COLA/CAP/CLIA audit preparations and corrections
  • LC-MS/MS method development
  • LC-MS/MS results certification
  • Pharmacogenomics translations
  • Cost/Sample evaluations and reductions
  • Clinical laboratory validation plans
  • Lab equipment selection
  • Personnel training
  • SOP drafting


WORK EXPERIENCE

July 2015 – September 2016

Analytical Chemist/Lab Manager, Pathology Partners Toxicology Division

October 2016 – October 2018

Director of Operations, ESA Labs and Codex Health 

January 2018 – Present

Co-owner, Beyond DNA, LLC 

May 2018 – Present

Director of Operations & Technical Supervisor, MedTech Laboratories 


CERTIFICATIONS/TRAINING

2019

Toxicological Chemist; National Registry of Certified Chemists

2017 

QuantStudio 12K Flex platform and software training

2015

LCMS Practical Maintenance & Troubleshooting; American Society for Mass Spectrometry

Introduction to GLP Regulations; American Society for Mass Spectrometry

2011

Teacher’s Certificate for the State of Arkansas and Missouri in: Life, Physical, Earth, and Space Sciences Grades 9-12



Urine Drug Testing Medications & Metabolites


This document will aid urine toxicology labs with properly linking their LIS drug library list with metabolites.


This document can serve as a guide for:

  1. >200 medications
  2. Adding medications to your LIS
  3. Linking metabolites to medications
  4. Training document-entry Team (Accessioners)
  5. Guiding Certifying Scientists
  6. Foundational document for compliance


Disclaimers:

  1. This is not a complete list of all medications from all countries
  2. Not all metabolites are included
  3. Importantly, glucuronidation and sulfation conjugation metabolites are not listed
  4. The major and minor designation for metabolites are relative to population genetics
  5. This document should not serve as guidance for billing for drug classes

Price$200.00

Seller


Additional Info

This document will aid urine toxicology labs with properly linking their LIS drug library list with metabolites.


This document can serve as a guide for:

  1. >200 medications
  2. Adding medications to your LIS
  3. Linking metabolites to medications
  4. Training document-entry Team (Accessioners)
  5. Guiding Certifying Scientists
  6. Foundational document for compliance


Disclaimers:

  1. This is not a complete list of all medications from all countries
  2. Not all metabolites are included
  3. Importantly, glucuronidation and sulfation conjugation metabolites are not listed
  4. The major and minor designation for metabolites are relative to population genetics
  5. This document should not serve as guidance for billing for drug classes

LC-MS/MS Validation Summary Document


This document is a user-friendly validation framework that has been used to pass CLIA and COLA inspections of High Complexity LC-MS/MS-based confirmation Laboratory Developed Tests for urine drug testing. The elements of accuracy, precision, linearity, etc. are simplified for ease of use and understanding.

Price$400.00

Seller


Additional Info

This document is a user-friendly validation framework that has been used to pass CLIA and COLA inspections of High Complexity LC-MS/MS-based confirmation Laboratory Developed Tests for urine drug testing. The elements of accuracy, precision, linearity, etc. are simplified for ease of use and understanding.